Remarkably, our study also revealed ARTS as a biomarker for tumor chemosensitivity, dependent on p53, because overexpression of ARTS enhanced, whereas depletion of ARTS impaired, chemotherapy-induced apoptosis in wild-type p53-harboring cancer cells (Hao et al., 2021a). Here, TP53 is linked to neoplasm.